226 related articles for article (PubMed ID: 1956764)
1. Antibody to hepatitis C (anti C 100-3) in French hemophiliacs.
Maisonneuve P; Laurian Y; Guerois C; Verroust F; Ferrer Le Coeur F; Couroucé AM; Noel L
Nouv Rev Fr Hematol (1978); 1991; 33(3):263-6. PubMed ID: 1956764
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan (northern province of Iran).
Mansour-Ghanaei F; Fallah MS; Shafaghi A; Yousefi-Mashhoor M; Ramezani N; Farzaneh F; Nassiri R
Med Sci Monit; 2002 Dec; 8(12):CR797-800. PubMed ID: 12503038
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C contributes to liver disease in children and adolescents with hemophilia.
Wagner N; Rotthauwe HW
Klin Padiatr; 1994; 206(1):40-4. PubMed ID: 7512169
[TBL] [Abstract][Full Text] [Related]
4. [Hepatitis C antibodies in children and adolescents with congenital blood coagulation disorders].
Zenz W; Hofmann H; Muntean W
Wien Klin Wochenschr; 1991; 103(3):69-72. PubMed ID: 1851352
[TBL] [Abstract][Full Text] [Related]
5. Virus safety of pasteurized factor VIII and factor IX concentrates: study in virgin patients.
Heimburger N; Karges HE; Weidmann E
Dev Biol Stand; 1987; 67():303-10. PubMed ID: 3038638
[TBL] [Abstract][Full Text] [Related]
6. Clinical and biological survey of haemophilia A and B patients infused with French heat-treated concentrates.
Parquet A; Boneu B; Bosser C; Cazenave JP; Dirat G; Gazengel G; Grunebaum L; Sultan Y; Verroust F; Wiesel ML
Nouv Rev Fr Hematol (1978); 1988; 30(4):205-7. PubMed ID: 3143099
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B and C virus infections in patients with hemophilia in Zahedan, southeast Iran.
Sharifi-Mood B; Eshghi P; Sanei-Moghaddam E; Hashemi M
Saudi Med J; 2007 Oct; 28(10):1516-9. PubMed ID: 17914511
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
9. [Prevention of transfusion-associated virus infections in hemophilic patients needing replacement therapy].
Meili EO
Beitr Infusionsther; 1989; 24():46-55. PubMed ID: 2481548
[TBL] [Abstract][Full Text] [Related]
10. The prevalence and interaction of human immunodeficiency virus and hepatitis B virus infections in Israeli hemophiliacs.
Brenner B; Schwartz S; Ben-Porath E; Tatarsky I; Varon D; Martinowitz U
Isr J Med Sci; 1991 Oct; 27(10):557-61. PubMed ID: 1955309
[TBL] [Abstract][Full Text] [Related]
11. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.
Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC
Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888
[TBL] [Abstract][Full Text] [Related]
12. [Prevalence of hepatitis A, B, C virus markers in Réunion (south hospital and Saint Pierre prison)].
Michault A; Faulques B; Sevadjan B; Troalen D; Marais A; Barau G
Bull Soc Pathol Exot; 2000 Feb; 93(1):34-40. PubMed ID: 10774493
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence of HCV, HBV and HIV infections among severe Polish haemophiliacs].
Windyga J; Grabarczyk P; Stefańska E; Buczma A; Szczepanik AB; Klukowska A; Mikulska M; Medyńska J; Brojer E
Przegl Epidemiol; 2008; 62(2):415-23. PubMed ID: 18807489
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C and pasteurised factor VIII and IX concentrates.
Klarmann D; Kreuz W; Auerswald G; Auberger K; Rabenau H; Gürtler L; Roggendorf M
Thromb Haemost; 1995 Apr; 73(4):736-7. PubMed ID: 7495095
[No Abstract] [Full Text] [Related]
15. Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan.
Toyoda H; Hayashi K; Murakami Y; Honda T; Katano Y; Nakano I; Goto H; Kumada T; Takamatsu J
J Med Virol; 2004 Jun; 73(2):195-9. PubMed ID: 15122792
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C infection among Dutch haemophilia patients: a nationwide cross-sectional study of prevalence and antiviral treatment.
Posthouwer D; Plug I; van der Bom JG; Fischer K; Rosendaal FR; Mauser-Bunschoten EP
Haemophilia; 2005 May; 11(3):270-5. PubMed ID: 15876273
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection.
Picchio GR; Nakatsuno M; Boggiano C; Sabbe R; Corti M; Daruich J; Pérez-Bianco R; Tezanos-Pinto M; Kokka R; Wilber J; Mosier D
J Med Virol; 1997 Jun; 52(2):219-25. PubMed ID: 9179772
[TBL] [Abstract][Full Text] [Related]
18. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
Devi KhS; Brajachand N; Singh HL; Singh YM
J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
[TBL] [Abstract][Full Text] [Related]
19. Serological markers of autoimmunity in patients with hemophilia A: the role of hepatitis C virus infection, alpha-interferon and factor VIII treatment in skewing the immune system toward autoreactivity.
Vianello F; Tison T; Tagariello G; Zerbinati P; Zanon E; Scarano L; Girolami A
Blood Coagul Fibrinolysis; 1999 Sep; 10(6):393-7. PubMed ID: 10493222
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
